TY  - GEN
AU  - Gez,Eliahu
AU  - Rubinov,Raphael
AU  - Gaitini,Diana
AU  - Meretyk,Shimon
AU  - Best,Lael-Anson
AU  - Native,Ofer
AU  - Stein,Avi
AU  - Erlich,Nahum
AU  - Beny,Alexander
AU  - Zidan,Jamal
AU  - Haim,Nissim
AU  - Kuten,Abraham
TI  - Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000
SN  - 0008-543X
PY  - 2002///1029
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - administration & dosage
KW  - Humans
KW  - Injections, Intravenous
KW  - Injections, Subcutaneous
KW  - Interferon-alpha
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Nephrectomy
KW  - Prospective Studies
KW  - Treatment Outcome
KW  - Vinblastine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1002/cncr.10842
ER  -